Skip to main content

Table 2 Characteristics of HCV study population

From: The high comorbidity burden of the hepatitis C virus infected population in the United States

    Received HCV treatment during study period
  Total (n = 7411) Yes (n = 3469) No (n = 3942)
  n % n % n %
Gender
Female 2750 37.1 1134 32.7 1616 41.0
Male 4661 62.9 2335 67.3 2326 59.0
Age category
0-19 18 0.2 3 0.1 15 0.4
10-19 51 0.7 18 0.5 33 0.8
20-29 142 1.9 55 1.6 87 2.2
30-39 716 9.7 342 9.9 374 9.5
40-49 3194 43.1 1583 45.6 1611 40.9
50-59 2714 36.6 1294 37.3 1420 36.0
60-64 329 4.4 137 3.9 192 4.9
65+ 247 3.3 37 1.1 210 5.3
Census Region
Midwest 305 4.1 142 4.1 163 4.1
Northeast 4730 63.8 2259 65.1 2471 62.7
South 700 9.4 368 10.6 332 8.4
West 369 5.0 134 3.9 235 6.0
Othera 1307 17.6 566 16.3 741 18.8
Health insurance type b
Health Maintainance Organization 3247 43.8 1500 43.2 1747 44.3
Individual Plans 302 4.1 142 4.1 16. 4.1
Point of Service 755 10.2 382 11.0 373 9.5
Preferred Provider Organization 2914 39.3 1405 40.5 1509 38.3
Other 167 2.3 39 1.1 128 3.2
Advanced liver disease 1462 19.7 1017 29.3 445 11.3
Cirrhosis 1335 18.0 926 26.7 409 10.4
Hepatocellular carcinoma 127 1.7 91 2.6 36 0.9
Drug use 1101 14.9 447 12.9 654 16.6
Alcohol use 485 6.5 166 4.8 319 8.1
  1. a Other region includes other regions and regions which were masked for confidentiality purposes
  2. b 26 patients had unknown health insurance type.